Organizer: IRB Barcelona
Date: Wednesday, 13 September 2017, 15.00h
Place: Aula Fèlix Serratosa, Parc Científic de Barcelona, Spain
Host: Marco Milán, IRB Barcelona
Abstract
Organizer: IRB Barcelona
Date: Wednesday, 13 September 2017, 15.00h
Place: Aula Fèlix Serratosa, Parc Científic de Barcelona, Spain
Host: Marco Milán, IRB Barcelona
Abstract
Organizer: IRB Barcelona
Date: Wednesday, 20 September 2017, 15.00h
Place: Aula Fèlix Serratosa, Parc Científic de Barcelona, Spain
Host: Jordi Casanova, IRB Barcelona
Abstract
Organizer: IRB Barcelona
Date: Wednesday, 27 September 2017, 15.00h
Place: Aula Felix Serratosa, Parc Científic de Barcelona, Spain
Host: Marco Milán, IRB Barcelona
Abstract
Genomics is moving for a static monodimensional picture, to a time dependent 3D structure. Chromatin is not any more a magic word used to represent a portion of the cell absorbing more colorant than the rest. Chromatin is now a plastic supramolecular structure composed of DNA and protein whose conformation regulates accessibility of the genes to the protein machinery that regulate their function. Nothing of the activity of the cell can be understood without considering the time-dependent three dimensional structure of chromatin.
Date: 15 - 17 November 2017
Place: Palauet Casades, carrer de Mallorca 283, Barcelona (Spain)
Early bird registration period: May 3 – July 31, 2017
Deadline for application for travel grants: June 30, 2017
Late registration period: August 1 – September 30, 2017
The cellular interactions that lead to well-organised tissues, organs and bodies display a collection of regulatory phenomena, or organizational principles, which are specific to this multicellular level. These include phenomena such as positional information across fields of equivalent cells, self-organising patterns, multi-scale feedback between tissue mechanics and gene regulation, and many others.
Metastasis is the main cause of cancer related deaths from solid tumors. Although significant progress has been made in identifying its genetic, molecular and cellular determinants, we still do not fully understand the metastatic process, hampering our ability to develop specific anti-metastatic therapies. Recent conceptual and technological advances are providing an unprecedented opportunity to address this problem.